Search

everythinglearnresearchcommunity

for

Search:↓

Stress may trigger hair loss by affecting immune protection in hair follicles.

A new treatment plan helps manage folliculitis decalvans effectively.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Hair transplants can cause hair loss if done while lichen planopilaris is active; wait until it's inactive for two years and check with a scalp biopsy first.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

Different types of stem cells in the skin contribute to the variety of melanoma forms.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.